TY  - GEN
AU  - Wykoff,Charles C
AU  - Brown,David M
AU  - Croft,Daniel E
AU  - Wong,Tien P
TI  - Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD
SN  - 1549-4713
PY  - 2013///1119
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Drug Resistance
KW  - Female
KW  - Humans
KW  - Intravitreal Injections
KW  - Male
KW  - Ranibizumab
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Visual Acuity
KW  - physiology
KW  - Wet Macular Degeneration
KW  - diagnosis
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ophtha.2013.06.030
ER  -